The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Intracellular Signals Mediating the Food Intake-Suppressive Effects of Hindbrain Glucagon-like Peptide-1 Receptor Activation
Open accessAbstract
Summary Glucagon-like-peptide-1 receptor (GLP-1R) activation within the nucleus tractus solitarius (NTS) suppresses food intake and body weight (BW), but the intracellular signals mediating these effects are unknown. Here, hindbrain (4th icv) GLP-1R activation by Exendin-4 increased PKA and MAPK activity and decreased phosphorylation of AMPK in NTS. PKA and MAPK signaling contribute to food intake and BW suppression by Exendin-4, as inhibitors RpcAMP and U0126 (4th icv), respectively, attenuated Exendin-4's effects. Hindbrain GLP-1R activation inhibited feeding by reducing meal number, not meal size. This effect was attenuated with stimulation of AMPK activity by AICAR (4th icv). The PKA, MAPK and AMPK signaling responses by Ex-4 were present in immortalized GLP-1R-expressing neurons (GT1-7). In conclusion, hindbrain GLP-1R activation suppresses food intake and BW through coordinated PKA-mediated suppression of AMPK and activation of MAPK. Pharmacotherapies targeting these signaling pathways, which mediate intake-suppressive effects of CNS GLP-1R activation, may prove efficacious in treating obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y.-B., Lee, A., Xue, B., Mu, J., Foufelle, F., Ferré, P., Birnbaum, M. J., et al. (2004) · Nature · doi:10.1038/nature02440 · Cited by 1,637
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man
Wettergren, A., Schjoldager, B., Mortensen, P. E., Myhre, J., Christiansen, J., & Holst, J. J. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01316798 · Cited by 670
Larsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
Key enzyme in leptin-induced anorexia
Niswender, K. D., Morton, G. J., Stearns, W. H., Rhodes, C. J., Myers, M. G., & Schwartz, M. W. (2001) · Nature · doi:10.1038/35101657 · Cited by 585
Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00650.x · Cited by 474 · cited 2×
“GLP-1Rs are widely expressed throughout the central nervous system (CNS) inmany sites relevant to energybalance regulation, including nuclei in the caudal brainstem (NTS; parabrachial nucleus), hypothalamus (lateral hypothalamus, LH; paraventricular hypothalamus, PVH), and basal forebrain (bed nucleus of stria termina…”
Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms
I˙meryüz, N., Yeğen, B. Ç., Bozkurt, A., Coşkun, T., Villanueva-Peñacarrillo, M. L., & Ulusoy, N. B. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.4.g920 · Cited by 432
Xue, B., & Kahn, B. B. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113217 · Cited by 338
Beak, S. A., Heath, M. M., Small, C. J., Morgan, D. G., Ghatei, M. A., Taylor, A. D., Buckingham, J. C., Bloom, S. R., & Smith, D. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci610 · Cited by 133 · cited 4×
“GLP-1R-Expressing GT1-7 Neurons Show Exendin-4-Mediated Increases in cAMP/PKA andMAPKSignaling,andSuppressionofAMPKSignaling Total cAMP levels were evaluated in GLP-1R-expressing GT1-7 neuronal cells (Beak et al., 1998; Yang et al., 2005) following 15 min of Ex-4 treatment (0.”
InfluentialCentral pre-proglucagon derived peptides: Opportunities for treatment of obesity
Larsen, P., Vrang, N., & Tang-Christensen, M. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454775 · Cited by 24
Research works printed but not linked: 45
- Chelikani, 2005, Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats, Am. J. Physiol. Regul. Integr. Comp. Physiol., 288, R1695, 10.1152/ajpregu.00870.2004 · DOI
- Daniels, 2003, Melanocortin receptor signaling through mitogen-activated protein kinase in vitro and in rat hypothalamus, Brain Res., 986, 1, 10.1016/S0006-8993(03)03162-7 · DOI
- Daniels, 2005, Divergent behavioral roles of angiotensin receptor intracellular signaling cascades, Endocrinology, 146, 5552, 10.1210/en.2005-0774 · DOI
- da Silva Xavier, 2003, Role for AMP-activated protein kinase in glucose-stimulated insulin secretion and preproinsulin gene expression, Biochem. J., 371, 761, 10.1042/bj20021812 · DOI · Paper page
- Dostmann, 1990, Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3′,5′-cyclic phosphorothioates, J. Biol. Chem., 265, 10484, 10.1016/S0021-9258(18)86973-3 · DOI · Paper page
- Dugan, 1999, Differential effects of cAMP in neurons and astrocytes. Role of B-raf, J. Biol. Chem., 274, 25842, 10.1074/jbc.274.36.25842 · DOI · Paper page
- Gomez, 2002, cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic beta-cells, J. Biol. Chem., 277, 48146, 10.1074/jbc.M209165200 · DOI · Paper page
- Gutzwiller, 1999, Glucagon-like peptide-1: a potent regulator of food intake in humans, Gut, 44, 81, 10.1136/gut.44.1.81 · DOI · Paper page
- Han, 2005, Hypothalamic AMP-activated protein kinase mediates counter-regulatory responses to hypoglycaemia in rats, Diabetologia, 48, 2170, 10.1007/s00125-005-1913-1 · DOI
- Hayes, 2006, Dorsal hindbrain 5-HT3 receptors participate in control of meal size and mediate CCK-induced satiation, Brain Res., 1103, 99, 10.1016/j.brainres.2006.05.058 · DOI
- Hayes, 2008, Dorsal hindbrain AMP-Kinase as an intracellular mediator of energy balance, Endocrinology, 150, 2175, 10.1210/en.2008-1319 · DOI
- Hayes, 2008, Caudal brainstem processing is sufficient for behavioral, sympathetic and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation, Endocrinology, 149, 4059, 10.1210/en.2007-1743 · DOI · Paper page
- Hayes, 2009, Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling, Endocrinology, 150, 2654, 10.1210/en.2008-1479 · DOI · Paper page
- Hayes, 2009, Dorsal hindbrain 5′-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance, Endocrinology, 150, 2175, 10.1210/en.2008-1319 · DOI
- Hayes, 2010, Role of the glucagon-like-peptide-1 receptor in the control of energy balance, Physiol. Behav., 100, 503, 10.1016/j.physbeh.2010.02.029 · DOI · Paper page
- Hayes, 2010, Endogenous leptin signaling in the caudal nucleus tractus solitarius and area postrema is required for energy balance regulation, Cell Metab., 11, 77, 10.1016/j.cmet.2009.10.009 · DOI · Paper page
- Holst, 2007, The physiology of glucagon-like peptide 1, Physiol. Rev., 87, 1409, 10.1152/physrev.00034.2006 · DOI · Paper page
- Huo, 2006, Divergent regulation of proopiomelanocortin neurons by leptin in the nucleus of the solitary tract and in the arcuate hypothalamic nucleus, Diabetes, 55, 567, 10.2337/diabetes.55.03.06.db05-1143 · DOI
- Hurley, 2006, Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP, J. Biol. Chem., 281, 36662, 10.1074/jbc.M606676200 · DOI · Paper page
- Kelly, 2007, Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP, Neuropsychopharmacology, 32, 577, 10.1038/sj.npp.1301099 · DOI
- Kim, 2005, Role of hypothalamic 5′-AMP-activated protein kinase in the regulation of food intake and energy homeostasis, J. Mol. Med., 83, 514, 10.1007/s00109-005-0659-z · DOI
- Kim, 2004, C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase, J. Biol. Chem., 279, 19970, 10.1074/jbc.M402165200 · DOI · Paper page
- Kim, 2004, Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase, Nat. Med., 10, 727, 10.1038/nm1061 · DOI · Paper page
- Kinzig, 2002, The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness, J. Neurosci., 22, 10470, 10.1523/JNEUROSCI.22-23-10470.2002 · DOI · Paper page
- Komatsu, 1989, Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide, Diabetes, 38, 902, 10.2337/diab.38.7.902 · DOI · Paper page
- Lovshin, 2009, Incretin-based therapies for type 2 diabetes mellitus, Nat. Rev. Endocrinol., 5, 262, 10.1038/nrendo.2009.48 · DOI · Paper page
- Ma, 2007, Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons, J. Neurosci., 27, 7125, 10.1523/JNEUROSCI.1025-07.2007 · DOI
- Mack, 2006, Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures, Int. J. Obes. (Lond.), 30, 1332, 10.1038/sj.ijo.0803284 · DOI
- McMahon, 1997, Decreased intake of a liquid diet in nonfood-deprived rats following intra-PVN injections of GLP-1 (7-36) amide, Pharmacol. Biochem. Behav., 58, 673, 10.1016/S0091-3057(97)90017-4 · DOI
- McMahon, 1998, PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats, Am. J. Physiol., 274, R23
- Merchenthaler, 1999, Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system, J. Comp. Neurol., 403, 261, 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5 · doi:10.1002/(sici)1096-9861(19990111)403:2<261::aid-cne8>3.0.co;2-5
- Mollet, 2004, Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats, Physiol. Behav., 81, 149, 10.1016/j.physbeh.2004.01.006 · DOI
- Moran, 1996, Fourth ventricular administration of glucagon-like peptide (7-36) amide (GLP-1) inhibits food intake in rats, Soc. Neurosci., 22, 15
- Morton, 2009, The action of leptin in the ventral tegmental area to decrease food intake is dependent on Jak-2 signaling, Am. J. Physiol. Endocrinol. Metab., 297, E202, 10.1152/ajpendo.90865.2008 · DOI
- Perfetti, 2000, Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function, Eur. J. Endocrinol., 143, 717, 10.1530/eje.0.1430717 · DOI
- Potes, 2010, Brainstem mechanisms of amylin-induced anorexia, Physiol. Behav., 100, 511, 10.1016/j.physbeh.2010.03.001 · DOI
- Ruttimann, 2009, Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms, Endocrinology, 150, 1174, 10.1210/en.2008-1221 · DOI · Paper page
- Scott, 2007, The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size, Am. J. Physiol. Regul. Integr. Comp. Physiol., 293, R983, 10.1152/ajpregu.00323.2007 · DOI
- Seo, 2008, Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats, Endocr. J., 55, 867, 10.1507/endocrj.K08E-091 · DOI
- Sheriff, 2003, Hypothalamic administration of cAMP agonist/PKA activator inhibits both schedule feeding and NPY-induced feeding in rats, Peptides, 24, 245, 10.1016/S0196-9781(03)00037-8 · DOI
- Sutton, 2004, Extracellular signal-regulated kinase 1/2 signaling pathway in solitary nucleus mediates cholecystokinin-induced suppression of food intake in rats, J. Neurosci., 24, 10240, 10.1523/JNEUROSCI.2764-04.2004 · DOI
- Sutton, 2005, Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus, Endocrinology, 146, 3739, 10.1210/en.2005-0562 · DOI
- Vossler, 1997, cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway, Cell, 89, 73, 10.1016/S0092-8674(00)80184-1 · DOI · Paper page
- Vrang, 2003, Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons, Am. J. Physiol. Regul. Integr. Comp. Physiol., 285, R470, 10.1152/ajpregu.00732.2002 · DOI · Paper page
- Yang, 2005, Expression of feeding-related peptide receptors mRNA in GT1-7 cell line and roles of leptin and orexins in control of GnRH secretion, Acta Pharmacol. Sin., 26, 976, 10.1111/j.1745-7254.2005.00118.x · DOI
Cited by
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170
“These actions were associated with acute reductions of food intake and blocked by co-administration of inhibitors of cAMP-dependent signaling (Hayes et al., 2011).”
BackgroundGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationSugar for the brain: the role of glucose in physiological and pathological brain function
Mergenthaler, P., Lindauer, U., Dienel, G. A., & Meisel, A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.07.001 · Cited by 1,612
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961
Alhadeff, A. L., Rupprecht, L. E., & Hayes, M. R. (2012) · Endocrinology · doi:10.1210/en.2011-1443 · Cited by 515
Self-citationGLP-1 physiology informs the pharmacotherapy of obesity
Drucker, D. J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101351 · Cited by 510
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Hindbrain Neurons as an Essential Hub in the Neuroanatomically Distributed Control of Energy Balance
Grill, H. J., & Hayes, M. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.015 · Cited by 485
Self-citationGraaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., et al. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011395 · Cited by 403
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 410
Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383
Common cellular and molecular mechanisms in obesity and drug addiction
Kenny, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3105 · Cited by 382
Hypothalamic AMPK: a canonical regulator of whole-body energy balance
López, M., Nogueiras, R., Tena-Sempere, M., & Diéguez, C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.67 · Cited by 309
GLP-1 and weight loss: unraveling the diverse neural circuitry
Kanoski, S. E., Hayes, M. R., & Skibicka, K. P. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2015 · Cited by 290
Self-citationKanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., & Hayes, M. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.022 · Cited by 273
Self-citationKanoski, S. E., & Grill, H. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.09.011 · Cited by 273
Self-citationSalcedo, I., Tweedie, D., Li, Y., & Greig, N. H. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01971.x · Cited by 259
GDF15 induces anorexia through nausea and emesis
Borner, T., Shaulson, E. D., Ghidewon, M. Y., Barnett, A. B., Horn, C. C., Doyle, R. P., Grill, H. J., Hayes, M. R., & De Jonghe, B. C. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.12.004 · Cited by 255
Self-citationA genetic map of the mouse dorsal vagal complex and its role in obesity
Ludwig, M. Q., Cheng, W., Gordian, D., Lee, J., Paulsen, S. J., Hansen, S. N., Egerod, K. L., Barkholt, P., Rhodes, C. J., Secher, A., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00363-1 · Cited by 186
Hsu, T. M., Hahn, J. D., Konanur, V. R., Lam, A., & Kanoski, S. E. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.175 · Cited by 176
Self-citationGlucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
Muscogiuri, G., DeFronzo, R. A., Gastaldelli, A., & Holst, J. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.001 · Cited by 171
Brain regulation of energy balance and body weight
Rui, L. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9261-9 · Cited by 168
Dissociable hindbrain GLP1R circuits for satiety and aversion
Huang, K.-P., Acosta, A. A., Ghidewon, M. Y., McKnight, A. D., Almeida, M. S., Nyema, N. T., Hanchak, N. D., Patel, N., Gbenou, Y. S. K., Adriaenssens, A. E., et al. (2024) · Nature · doi:10.1038/s41586-024-07685-6 · Cited by 166
Meng, J., Ma, X., Wang, N., Jia, M., Bi, L., Wang, Y., Li, M., Zhang, H., Xue, X., Hou, Z., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.02.002 · Cited by 155
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146
Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance
Reiner, D. J., Mietlicki-Baase, E. G., McGrath, L. E., Zimmer, D. J., Bence, K. K., Sousa, G. L., Konanur, V. R., Krawczyk, J., Burk, D. H., Kanoski, S. E., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3579-15.2016 · Cited by 133
Self-citationFortin, S. M., Lipsky, R. K., Lhamo, R., Chen, J., Kim, E., Borner, T., Schmidt, H. D., & Hayes, M. R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8071 · Cited by 127
Self-citationRonveaux, C. C., Tomé, D., & Raybould, H. E. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.206029 · Cited by 124
Cheng, W., Gonzalez, I., Pan, W., Tsang, A. H., Adams, J., Ndoka, E., Gordian, D., Khoury, B., Roelofs, K., Evers, S. S., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.12.012 · Cited by 123
Alhadeff, A. L., & Grill, H. J. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00179.2014 · Cited by 111
Self-citationVarin, E. M., Mulvihill, E. E., Baggio, L. L., Koehler, J. A., Cao, X., Seeley, R. J., & Drucker, D. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.055 · Cited by 104
Alhadeff, A. L., Mergler, B. D., Zimmer, D. J., Turner, C. A., Reiner, D. J., Schmidt, H. D., Grill, H. J., & Hayes, M. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.246 · Cited by 102
Self-citationObesity: pathophysiology and therapeutic interventions
Kong, Y., Yang, H., Nie, R., Zhang, X., Zuo, F., Zhang, H., & Nian, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00264-9 · Cited by 89
Costa, A., Ai, M., Nunn, N., Culotta, I., Hunter, J., Boudjadja, M. B., Valencia-Torres, L., Aviello, G., Hodson, D. J., Snider, B. M., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101407 · Cited by 79
McKay, N. J., Kanoski, S. E., Hayes, M. R., & Daniels, D. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00472.2011 · Cited by 79
Self-citationBurmeister, M. A., Ayala, J., Drucker, D. J., & Ayala, J. E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00446.2012 · Cited by 64
Guerrero-Hreins, E., Goldstone, A. P., Brown, R. M., & Sumithran, P. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110303 · Cited by 62
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Reiss, A. B., Gulkarov, S., Lau, R., Klek, S. P., Srivastava, A., Renna, H. A., & De Leon, J. (2025) · Biomolecules · doi:10.3390/biom15030408 · Cited by 58
“Reductions in food intake and body weight have been found, implying that both the hypothalamus and brainstem are important in the control of energy intake and body weight [119,120].”
Yang, X., Qiang, Q., Li, N., Feng, P., Wei, W., & Hölscher, C. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.844697 · Cited by 58
GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
Li, Q.-X., Gao, H., Guo, Y.-X., Wang, B.-Y., Hua, R.-X., Gao, L., Shang, H.-W., Lu, X., & Xu, J.-D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721198 · Cited by 56
Chen, X.-Y., Chen, L., Yang, W., & Xie, A.-M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.793004 · Cited by 52
Chen, Z., Deng, X., Shi, C., Jing, H., Tian, Y., Zhong, J., Chen, G., Xu, Y., Luo, Y., & Zhu, Y. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178239 · Cited by 48
Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis
Borner, T., Workinger, J. L., Tinsley, I. C., Fortin, S. M., Stein, L. M., Chepurny, O. G., Holz, G. G., Wierzba, A. J., Gryko, D., Nexø, E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107768 · Cited by 39
Self-citationGLP-1 neurons form a local synaptic circuit within the rodent nucleus of the solitary tract
Card, J. P., Johnson, A. L., Llewellyn‐Smith, I. J., Zheng, H., Anand, R., Brierley, D. I., Trapp, S., & Rinaman, L. (2018) · Journal of Comparative Neurology · doi:10.1002/cne.24482 · Cited by 38
McKay, N. J., & Daniels, D. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12086 · Cited by 37
Fortin, S. M., Chen, J. C., Petticord, M. C., Ragozzino, F. J., Peters, J. H., & Hayes, M. R. (2023) · Science Advances · doi:10.1126/sciadv.adh0980 · Cited by 32
Ngabea, M. A., & Dimeji, I. Y. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152822 · Cited by 35
GLP-1/dexamethasone inhibits food reward without inducing mood and memory deficits in mice
Décarie-Spain, L., Fisette, A., Zhu, Z., Yang, B., DiMarchi, R. D., Tschöp, M. H., Finan, B., Fulton, S., & Clemmensen, C. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.035 · Cited by 27
Zhu, C., Li, H., Kong, X., Wang, Y., Sun, T., & Wang, F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.819470 · Cited by 26
Fortin, S. M., & Roitman, M. F. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.11.021 · Cited by 11
Fortin, S. M., Chen, J., & Hayes, M. R. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112870 · Cited by 10
Self-citationLai, S., Kang, Z., Sun, J., Wang, Z., Xu, Y., Xing, S., Feng, M., Wang, Y., & Liu, H. (2025) · Brain Sciences · doi:10.3390/brainsci15050480 · Cited by 9
Metadata
- Authors
- Hayes, M. R., Leichner, T. M., Zhao, S., Lee, G. S., Chowansky, A., Zimmer, D., De Jonghe, B. C., Kanoski, S. E., Grill, H. J., & Bence, K. K.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 13
- Issue
- 3
- Pages
- 320-330
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2028099278
- Cited by
- 234
- References
- 10
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-04-12)
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 905 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.